Invictus MD Strategies Corp Stock Toronto S.E.
Equities
GENE
CA46183X2086
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
Sales 2018 | 2.36 3.23 | Sales 2019 | 4.69 6.4 | Capitalization | 104M 141M |
---|---|---|---|---|---|
Net income 2018 | -19M -25.92M | Net income 2019 | -35M -47.76M | EV / Sales 2018 | 45,833,024 x |
Net cash position 2018 | 37.59M 51.29M | Net Debt 2019 | 3.85M 5.25M | EV / Sales 2019 | 22,877,117 x |
P/E ratio 2018 |
-5.87
x | P/E ratio 2019 |
-2.45
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 6.83% |
Managers | Title | Age | Since |
---|---|---|---|
Imran Haider
CEO | Chief Executive Officer | - | - |
Trevor Dixon
BRD | Director/Board Member | - | 19-05-08 |
Larry Heinzlmeir
IRO | Public Communications Contact | - | 17-01-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Dixon
BRD | Director/Board Member | - | 19-05-08 |
Jagdeep Gupta
BRD | Director/Board Member | - | 22-02-21 |
Greg Macdonald
BRD | Director/Board Member | - | 21-01-25 |
1st Jan change | Capi. | |
---|---|---|
+37.12% | 6.02B | |
-22.80% | 4.19B | |
+5.44% | 3.25B | |
-19.45% | 2.87B | |
-10.35% | 2.37B | |
+42.72% | 1.89B | |
-5.87% | 1.58B | |
-18.53% | 1.54B | |
-15.33% | 1.5B |
- Stock Market
- Equities
- IVITF Stock
- GENE Stock